Clinical trial
Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19
NCT04429763 is registered in ClinicalTrials.gov with Trustem as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19
- Lead sponsor
- Trustem
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2020
- Completion date
- November 30, 2020
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.